The Bay Area's booming biotech sector got another shot in the arm after a fast-growing cancer diagnostics company agreed to take over two of three buildings under construction at one of the region's yet-to-be-completed life sciences campuses.
The Bay Area's booming biotech sector got another shot in the arm after a fast-growing cancer diagnostics company agreed to take over two of three buildings under construction at one of the region's yet-to-be-completed life sciences campuses.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
259 Grand Ave, South San Francisco, CA